Most cancer immunotherapy research has targeted effector T cells, but a new study steps back and considers: What if the problem isn’t with the effector T cells, but starts higher up the cellular chain? And so researchers looked at naive T cells -- a type of immune cell that hasn’t yet been triggered to fight.
Healthy cells migrate only under special circumstances, such as in the early development of an embryo or when new skin cells and blood vessels move in to repair a wound. For a cancer cell to gain access to the body’s major highways -- the blood vessels and lymphatic system -- it has to invade through something.
This calendar only shows dates when events for Cancer Center members and trainees are occurring. If you are interested in seeing a calendar of ALL events, please visit the events calendar.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Research has shown that whether or not a patient is married makes a difference in how well -- or not -- a patient does, including for patients with cancer. What researchers don't understand is exactly why being married makes such a difference.
Women who pursue a more aggressive surgery for early stage breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Rogel Cancer Center researchers.
According to new research by Michigan Medicine, more than 10 percent of people who had never taken opioids prior to curative-intent surgery for cancer continued to take the drugs three to six months later. The risk is even greater for those who are treated with chemotherapy after surgery.
MENU